---

$1,206.56

+78.8690 ( +6.99% ) 3.7M

Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.

Open	$1,206.56
Previous Close	$1,127.69
Volume	3.7M
Market Cap	$1,005.61B
Day Range	$1,119.50 - $1,207.61
52 Week Range	$623.78 - $1,207.61
Shares Outstanding	891.74M
Change %	+6.99%
Net Change	▲ 78.8690
Insider Ownership	N/A
Exchange	NYSE
Sector	Basic Materials
Industry	PHARMACEUTICAL PREPARATIONS
IPO Year	1970
Country	United States

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-08-15	Buy	715.00	Montarce Lucas
2025-08-14	Buy	758.00	Alvarez Ralph
2025-08-14	Buy	758.00	Alvarez Ralph
2025-08-13	Buy	1000.00	Van Naarden Jacob
2025-08-12	Buy	1632.00	Ricks David A
2025-08-12	Buy	1000.00	Skovronsky Daniel
2025-08-12	Buy	117.00	Sulzberger Gabrielle
2025-08-12	Buy	686.00	Fyrwald J Erik
2025-08-12	Buy	686.00	Fyrwald J Erik
2025-08-08	Buy	200.00	JACKSON JAMERE